Approvals/TGA/GLYXAMBI 25 mg/5 mg empagliflozin/linagliptin 25mg/5mg film coated tablet blister pack

Approved

STANDARD

GLYXAMBI 25 mg/5 mg empagliflozin/linagliptin 25mg/5mg film coated tablet blister pack

Boehringer Ingelheim Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: b2425f016e991a05
Product Name: GLYXAMBI 25 mg/5 mg empagliflozin/linagliptin 25mg/5mg film coated tablet blister pack
Artg Id: 263557
Artg Name: GLYXAMBI 25 mg/5 mg empagliflozin/linagliptin 25mg/5mg film coated tablet blister pack
Sponsor: Boehringer Ingelheim Pty Ltd
Company Detail Path: /organization/boehringer-ingelheim-pty-ltd
Artg Date: 2016-12-19
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/8a7e9567bec5acd283a0ed28f922e8c2.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/f21184be274d97392a7aff0f536b3cfe.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

b2425f016e991a05

Type

Standard